.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Julphar
Chubb
Novartis
McKesson
Mallinckrodt
Deloitte
Covington
Merck
Harvard Business School

Generated: November 24, 2017

DrugPatentWatch Database Preview

Drug Master Files for: Glaxo

« Back to Dashboard
DMF No. Status Type Submission Date Holder Subject
981III7/22/1966LABORATORIES GLAXO EVANSCARRAGRRIN DERIVATIVE C.16
1507III3/27/1970GLAXO WELLCOME INCMANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN GREENVILLE, NORTH CAROLINA.
1820III11/10/1971GLAXO LABORATORIES SACEPHALEXIN
1946III5/24/1972GLAXO WELLCOME INCFACILITIES & CONTROLS OF THE WELLCOME FOUNDATION IN KENT ENGLAND
2494III7/23/1975GLAXO LABORATORIES SAMEGESTROL ACETATE
2716AII8/10/1976SMITHKLINE BEECHAM CORP DBA GLAXOSMITHKLINECIMETIDINE AND CIMETIDINE HCL
4094III3/6/1981GLAXO WELLCOME INCFACILS AND GEN OPER PROCEDS AT THE ULVERSTON PLANT
4100III3/6/1981GLAXOSMITHKLINE7-ACA TOSYLATE
4106III3/6/1981GLAXO WELLCOME INCCEPHALOSPORINS FILLING UNIT LOC IN BERNARD CASTLE, COUNTY DURHAM ENG.
4243III8/5/1981GLAXO WELLCOME INCMANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN MONTROSE, ANGEES, SCOTLAND.
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
UBS
Medtronic
Teva
Queensland Health
Boehringer Ingelheim
Cantor Fitzgerald
Chubb
Federal Trade Commission
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot